GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QHSLab Inc (OTCPK:USAQ) » Definitions » Cash Conversion Cycle

QHSLab (QHSLab) Cash Conversion Cycle : -21.84 (As of Mar. 2024)


View and export this data going back to 1990. Start your Free Trial

What is QHSLab Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

QHSLab's Days Sales Outstanding for the three months ended in Mar. 2024 was 18.85.
QHSLab's Days Inventory for the three months ended in Mar. 2024 was 13.93.
QHSLab's Days Payable for the three months ended in Mar. 2024 was 54.62.
Therefore, QHSLab's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2024 was -21.84.


QHSLab Cash Conversion Cycle Historical Data

The historical data trend for QHSLab's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QHSLab Cash Conversion Cycle Chart

QHSLab Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 664.79 57.68 1.51 -10.70

QHSLab Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.29 -64.02 -83.80 -63.33 -21.84

Competitive Comparison of QHSLab's Cash Conversion Cycle

For the Medical Devices subindustry, QHSLab's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QHSLab's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QHSLab's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where QHSLab's Cash Conversion Cycle falls into.



QHSLab Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

QHSLab's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=15.41+22.85-48.96
=-10.70

QHSLab's Cash Conversion Cycle for the quarter that ended in Mar. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=18.85+13.93-54.62
=-21.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QHSLab  (OTCPK:USAQ) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


QHSLab Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of QHSLab's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


QHSLab (QHSLab) Business Description

Traded in Other Exchanges
N/A
Address
901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. It is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
Executives
Troy James Grogan director, 10 percent owner, officer: CEO/Director 5480 N OCEAN DR B1D, SINGER ISLAND FL 33404
Richard J Rubin director, 10 percent owner, officer: CEO & Chairman 90 JOHN STREET, SUITE 626, NEW YORK NY 10038

QHSLab (QHSLab) Headlines

From GuruFocus

QHSLab. Issues Update and Investor Presentation May 2022

By GuruFocusNews GuruFocusNews 05-09-2022

QHSLab. Issues Update and Investor Presentation May 2022

By GuruFocusNews GuruFocusNews 07-08-2022

QHSLab. Issues Update and Investor Presentation May 2022

By GuruFocusNews GuruFocusNews 06-18-2022